What is ISO/TR 24971:2020?

ISO/TR 24971:2020 is a technical report that provides comprehensive, non-mandatory guidance on the development, implementation, and maintenance of a risk management system for medical devices according to ISO 14971:2019. As a companion document to the normative ISO 14971 standard, it offers detailed explanations, practical examples, and clarifications to help manufacturers effectively apply risk management principles.

Unlike the normative requirements in ISO 14971, the guidance in ISO/TR 24971 is informative and provides manufacturers with flexibility in how they implement risk management processes. The technical report helps bridge the gap between the standard's requirements and practical implementation, offering insights from the international experts who developed ISO 14971.

Why is ISO/TR 24971:2020 important?

ISO/TR 24971:2020 is important because it provides the practical interpretation and application guidance that manufacturers need to implement ISO 14971:2019 effectively and consistently. While ISO 14971 specifies what must be done, ISO/TR 24971 explains how to do it, offering critical context that helps manufacturers avoid common pitfalls and misinterpretations.

Benefits of using ISO/TR 24971:2020

Clarifies complex requirements: The technical report provides detailed explanations of difficult concepts such as benefit-risk analysis, risk acceptability policies, and reasonably foreseeable misuse, helping manufacturers interpret and implement these requirements correctly.

Practical implementation guidance: With concrete examples and detailed annexes on topics like hazard identification techniques and risk analysis methods, manufacturers receive actionable guidance for building effective risk management systems rather than just theoretical requirements.

Addresses industry-specific challenges: Annex E provides specific guidance for in vitro diagnostic medical devices, recognizing their unique characteristics and helping IVD manufacturers apply risk management principles appropriately to their products.

Facilitates consistency across products: The guidance helps organizations establish consistent risk management methodologies across different product lines and development teams, improving organizational efficiency and quality.